Jump to ContentJump to Main Navigation

Online

149,00 € / $224.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
August 2011
ISSN:
2191-0251
DOI:
10.1515/jpem.2011.204

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 149.00
RRP for USA, Canada, Mexico
US$ 224.00 *
Print
Individual Subscription Online only
Euro [D] 873.00
RRP for USA, Canada, Mexico
US$ 1310.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1048.00
RRP for USA, Canada, Mexico
US$ 1572.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Zadik, Zvi

Editorial Board Member: Cassorla, Fernando / Cutfield, Wayne / de Muinck Keizer-Schrama, Sabine M.P.F. / Fideleff, Hugo L. / LaFranch, Stephen H. / Lanes M. D., Roberto / Levitsky, Lynne / Lippe, Barbara / Pfäffle, Roland / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Kiess, Wieland

12 Issues per year

IMPACT FACTOR 2011: 0.875
5-year IMPACT FACTOR: 1.026

VolumeIssuePage

Issues

Development and linear growth in diabetic children receiving insulin pigment

Li Mao1 / 1 / Feng Ji1 / Shujun Lv1

1Department of Endocrinology, Huaian No. 1 People’s Hospital Affiliated to Nanjing Medical University, Huaian, Jiangsu Province, China

Corresponding author: Weiping Lu, Department of Endocrinology, Huaian No. 1 People’s Hospital Affi liated to Nanjing Medical University, Beijingxilu 6, Huaian City, Jiangsu Province, China Phone: +086-517-80872628, Fax: +086-517-84922412

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 7-8, Pages 433–436, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2011.204, August 2011

Abstract

Objective: The aim of this study was to ascertain if there are differences in the development and linear growth between a group of diabetic children who had been receiving insulin pigment and healthy children.

Methods: A total of 57 Chinese children with type 1 diabetes diagnosed at the age from 6 to 10 years old (26 boys and 31 girls) were included in the study. Their height and weight and development conditions were recorded until they reached their 18th birthday.

Results: Diabetic children were taller than healthy children at the onset of diabetes, even though there was no significant difference between them [male height standard deviation score (SDS): 0.34±0.93, female height SDS: 0.38±0.50]. When they reached their final height, they were slightly shorter than the healthy group. However, there were still no significant differences between these two groups (male height SDS: –0.42±0.95, female height SDS: –0.60±0.98). The median age at onset of puberty, 12.62 years in boys and 11.13 years in girls, was significantly delayed in diabetic boys compared to 10.55 years in healthy boys and 9.2 years in healthy girls. The median age at menarche in diabetic girls (14.15 years) was also delayed compared with 12.27 years in healthy girls. The majority of these diabetic children were thinner than the healthy children when they were diagnosed [male body mass index (BMI): 14.45±1.35 kg/m2vs. 16.08±0.59 kg/m2, t=–0.63, p<0.05; female BMI: 13.50±1.87 kg/m2vs. 15.46±0.45 kg/m2, t=–6.67, p<0.05]; however, as they reached their final height, they became fatter, especially the girls (male BMI: 21.43±1.62 kg/m2vs. 20.8±0.00 kg/m2, t=1.97, p>0.05; female BMI: 23.95±2.37 kg/m2vs. 20.3±0.00 kg/m2, t=8.60, p<0.05).

Conclusion: Even with well-controlled glucose levels, the development of children with diabetes who had been receiving insulin pigment were still adversely affected. However, linear growth had only been slightly affected. All patients, especially girls, became fatter when they reached their final height.

Keywords: child; diabetes mellitus, type 1; final height; growth and development

Comments (0)

Please log in or register to comment.